Abstract
Sleep disorders are a significant issue in the nursing home population, with prevalence rates from 6% to 65%. They can lead to several deleterious effects, such as increasing malaise, falls, and cognitive decline. There are a variety of treatment options, with nonpharmacologic interventions being first line. If nonpharmacologic measures fail, pharmacotherapy can be considered. Melatonin agonists, select antidepressants, suvorexant, and magnesium supplements have data to support their use in the elderly patient with minimal side effects. Medications with safety profiles that indicate the risks may outweigh the benefits should be avoided. These include benzodiazepines, nonbenzodiazepine hypnotics, antihistamines, antipsychotics, and most tricyclic antidepressants. Additionally, the lowest effective dose of any medication is recommended to minimize adverse effects. [ Psychiatr Ann. 2018;48(6):271–278.]
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
